Rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy.

Zhao, Rongqing; Xiao, Qian; Li, Maohua; Ren, Wenlin; Xia, Chenxi; Liu, Xudong; Li, Yingzi; Tan, Tan; Wu, Dianqing; Sun, Le

Zhao, Rongqing; Xiao, Qian; Li, Maohua; Ren, Wenlin; Xia, Chenxi; Liu, Xudong; Li, Yingzi; Tan, Tan; Wu, Dianqing; Sun, Le.

Afiliação

Zhao R; AbMax BioPharmaceuticals Co., LTD, Beijing 101111, China.
Xiao Q; AnyGo Technology Co., LTD, Beijing 100122, China.
Li M; Vascular Biology and Therapeutic Program and Department of Pharmacology, Yale School of Medicine, New Haven 201942, USA.
Ren W; AbMax BioPharmaceuticals Co., LTD, Beijing 101111, China.
Xia C; AbMax BioPharmaceuticals Co., LTD, Beijing 101111, China.
Liu X; AbMax BioPharmaceuticals Co., LTD, Beijing 101111, China.
Li Y; AbMax BioPharmaceuticals Co., LTD, Beijing 101111, China.
Tan T; AbMax BioPharmaceuticals Co., LTD, Beijing 101111, China.
Wu D; Hengyang Medical College, University of South China, Hengyang 421001, China.
Sun L; Vascular Biology and Therapeutic Program and Department of Pharmacology, Yale School of Medicine, New Haven 201942, USA.

Antib Ther ; 3(2): 63-70, 2020 Apr.

Article em En | MEDLINE | ID: mdl-32391516

Palavras-chave

DKK2; immunotherapy; monoclonal antibody; neutralizing epitope; rational peptide design

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Antib Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google